APA (7th ed.) Citation
(2026). Kisspeptin improves local ovarian insulin resistance in PCOS by modulating the PI3K/AKT/GLUT4 signaling pathway. PLOS ONE.
Chicago Style (17th ed.) Citation
"Kisspeptin Improves Local Ovarian Insulin Resistance in PCOS by Modulating the PI3K/AKT/GLUT4 Signaling Pathway." PLOS ONE 2026.
MLA (9th ed.) Citation
"Kisspeptin Improves Local Ovarian Insulin Resistance in PCOS by Modulating the PI3K/AKT/GLUT4 Signaling Pathway." PLOS ONE, 2026.
Warning: These citations may not always be 100% accurate.